MedPath

A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus

Completed
Conditions
Cardiovascular Risk Factors
Systemic Lupus Erythematosus
Metabolic Syndrome
Registration Number
NCT00982670
Lead Sponsor
Far Eastern Memorial Hospital
Brief Summary

An increased prevalence of the metabolic syndrome has been found in patients with systemic lupus erythematosus in recent years.

Detailed Description

This study will investigate the prevalence of the metabolic syndrome in patients with SLE in Taiwan. We expect our study will provide further understanding of the association between SLE and metabolic syndrome, which may give direction to prevent late cardiovascular morbidity and mortality in SLE patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Persons aged 18 and above.
  • Persons fulfill the diagnostic criteria of the 1997 American College of Rheumatology for systemic lupus erythematosus in the patient group.
Exclusion Criteria
  • Exclude a history myocardial infarction, angina or stroke.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The prevalence of the metabolic syndrome in patients with systemic lupus erythematosus in TaiwanOne year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Far Eastern Memorial Hospital

🇨🇳

Pan-Chiao, Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath